The new coronavirus variant Omicron is called to be a super spreader. It is spreading like wildfire in many European countries. Hence researchers and scientists from all over the world are trying to find a solution to this new variant. Pfizer says it is here with one. In a laboratory test, BioNTech and Pfizer’s Covid-19 vaccine was demonstrated to have a neutralising effect against the novel Omicron strain after three doses.
In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech and Pfizer said that two vaccine doses resulted in significantly lower neutralising antibodies, but that the third dose of their vaccine increased neutralising antibodies by a factor of 25. They also stated that if necessary, an Omicron-based vaccine can be delivered in March 2022.
